Phosphatidylserine, CAS# 51446-62-9, is a Plant extracts manufactured through plant extraction, available as Yellow or Brown Yellow Powder. Phosphatidylserine is widely used as nutrition supplements. It is widely accepted as safe food additive in many countries.
No significant side effects reported.
As Phosphatidylserine Side Effects is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Phosphatidylserine Side Effects for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
There is no evidence that Phosphatidylserine Side Effects could have any negative effects on these vulnerable groups. It should be safe to use Phosphatidylserine Side Effects in food for newborns and pregnant. However, we still recommend consumers to consult professionals before using large quantity of Phosphatidylserine Side Effects for long period in food for newborns or pregnant.
Though Phosphatidylserine Side Effects is not on FDA's GRAS exemption list, it's still widely accepted as safe food additive in many countries including USA with specific limit on dosage.
No health issues about Phosphatidylserine Side Effects reported up to now.
1. The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. [Clin Interv Aging. 2013]
Author: Richter Y, Herzog Y, Lifshitz Y, Hayun R, Zchut S.
2. Phosphatidylserine increases IKBKAP levels in a humanized knock-in IKBKAP mouse model. [Hum Mol Genet. 2013 Jul 15]
Author: Bochner R, Ziv Y, Zeevi D, Donyo M, Abraham L, Ashery-Padan R, Ast G.
3. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. [J Hum Nutr Diet. 2014 Apr]
Author: Hirayama S, Terasawa K, Rabeler R, Hirayama T, Inoue T, Tatsumi Y, Purpura M, Jäger R.
4. Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension. [Eur Psychiatry. 2013 Aug]
Author: Manor I, Magen A, Keidar D, Rosen S, Tasker H, Cohen T, Richter Y, Zaaroor-Regev D, Manor Y, Weizman A.